STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (22,134,640)	$ (31,837,205)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	633,529	650,131
Share based payments for services	856,025	530,736
Share-based payments for interest	0	80,716
Equity based compensation	4,428,174	2,743,267
Common stock contributed to 401(k) plan	143,878	145,090
Shares issued for settlement of clinical research costs	3,400,000	5,507,400
Loss prepaid research and development	0	471,157
Loss on derivative instruments	760,603	8,643,561
Amortization of debt discount	0	1,956,424
Inducement expense	0	291,234
Capitalized lease interest	128,194	168,037
(Increase)/decrease in assets:
Receivables	55,892	99,824
Prepaid expenses	(137,768)	153,102
Inventory used for R&D and manufacturing	(137,125)	27,284
Deposits	0	150,000
Increase/(decrease) in liabilities:
Accounts payable	(4,084,410)	(2,514,488)
Accrued expenses	(170,878)	(731,388)
Due to employees	(55,499)	71,110
Other liabilities	(6,660)	4,450
Net cash used in operating activities	(16,320,685)	(13,389,558)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of equipment	(177,779)	(1,015)
Expenditures for patent costs	(158,060)	(57,125)
Net cash used in investing activities	(335,839)	(58,140)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock and warrants	0	11,792,241
Proceeds from the purchase of stock by officers and directors	291,997	385,000
Payments of stock issuance costs	(163,364)	(195,589)
Proceeds from exercise of warrants	14,517,260	9,412,964
Payments on obligations under capital lease	(5,121)	(6,312)
Net cash provided by financing activities	14,791,254	21,388,304
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS	(1,865,270)	7,940,606
CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR	10,310,044	2,369,438
CASH AND CASH EQUIVALENTS, END OF YEAR	8,444,774	10,310,044
SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Plant, property and equipment purchases included in accounts payable	17,329	0
Prepaid amount under consulting services paid with issuance of common stock	22,563	162,452
Conversion of notes payable to common stock	0	2,294,300
Exercise of derivative liabilities	3,589,357	1,379,899
Lease payments included in accounts payable at year end	441	415
Stock issuance costs included in current liabilities	15,580	46,599
Cash paid for interest expense	$ 1,809,242	$ 1,750,897